Sort by
Keyphrases
Cardiovascular Disease
68%
Nigeria
65%
Hypertension
61%
India
54%
Hypertension Management
40%
Cardiovascular Prevention
37%
Polypill
37%
Heart Failure
36%
Cardiovascular Health
33%
Low-middle Income Countries
31%
World Health Organization
29%
Kerala
28%
Blood Pressure
27%
Cardiovascular Risk
25%
Confidence Interval
24%
Acute Coronary Syndrome
23%
Cardiovascular Mortality
23%
Risk Factors
23%
Randomized Controlled Trial
22%
Atherosclerotic Cardiovascular Disease (ASCVD)
21%
Heart Failure with Preserved Ejection Fraction (HFpEF)
21%
United States
21%
Fixed-dose Combination Therapy
19%
Blood Pressure Lowering
19%
Federal Capital Territory
19%
Fixed-dose Combination
18%
Heart Disease
17%
Heart Stroke
17%
Ischemic Heart Disease
17%
Disease Statistics
16%
Stroke Index
16%
Randomized Clinical Trial
15%
Patients with Heart Failure
15%
Secondary Prevention
14%
Peripheral Arterial Disease
14%
Primary Healthcare Centers
14%
Blood Pressure Control
13%
Clinical Outcomes
13%
Systolic Blood Pressure
13%
Healthcare Workers
13%
Usual Care
12%
Meta-analysis
12%
Myocardial Infarction
12%
Essential Medicines
12%
Presentation Management
12%
Quality Improvement Intervention
12%
Tobacco Cessation
12%
Risk Ratio
12%
Quality of Care
11%
Non-communicable Diseases
11%
Medicine and Dentistry
Cardiovascular Disease
100%
Cardiovascular System
74%
Blood Pressure
49%
Apoplexy
42%
Congestive Heart Failure
38%
Primary Health Care
36%
Polypill
35%
Combination Therapy
28%
Health Care Personnel
28%
Systematic Review
27%
Low and Middle Income Countries
26%
Quality Improvement
23%
Primary Prevention
21%
Acute Coronary Syndrome
21%
Arteriosclerotic Heart Disease
21%
Health Care Cost
19%
Cross Sectional Study
19%
Diseases
19%
Secondary Prevention
19%
Randomized Controlled Trial
17%
Heart Disease
17%
Mixed Methods
17%
Heart Failure with Reduced Ejection Fraction
16%
Ischemic Heart Disease
16%
Myocardial Infarction
15%
Diabetes
14%
Community Health
14%
Meta-Analysis
14%
Prevalence
14%
Acetylsalicylic Acid
13%
Cardiovascular Risk
13%
Essential Medicines
12%
Randomized Clinical Trials
11%
Odds Ratio
11%
Diabetes Mellitus
11%
Cardiovascular Disease Prevention
11%
Mortality Rate
10%
Time Series Analysis
10%
Atherosclerosis
10%
Atrial Fibrillation
10%
Systolic Blood Pressure
10%
Primary Outcome
10%
Cardiovascular Mortality
9%
Public Health
9%
Clinician
9%
Quality of Life
9%
Acute Decompensated Heart Failure
8%
Prematurity
8%
Disease
8%
Non Communicable Disease
8%